Disclosure Of Share-Based Payment Arrangements [Text Block]

OSE Immunotherapeutics - Filing #831399

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of share-based payment arrangements [text block]
Expense from share-based payment transactions, alternative [abstract]
Expense from share-based payment transactions with employees
2 034 EUR
3 130 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.